Patents by Inventor K. David G. Edwards

K. David G. Edwards has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Renoprotective treatments employing vasodilator compounds
    Patent number: 4532135
    Abstract: A treatment method and substances have been found to reduce the risk of incurring renal damage or failure. Vasodilators useful for the treatment of hypertension have been found to lower cholesterol levels and prevent renal failure or damage. These substances are administered alone or in combination with other substances useful in the treatment of hyperlipidemia such as phenoxyacetic acid derivatives. Suitable vasodilators include: hydralazine hydrochloride and functionally similar agents such as endralazine, trimazosin, minoxidil, and diazoxide; prazosin hydrochloride and functionally similar agents such as doxazosin, triodazosin, phentolamine hydrochloride, phenoxybenzamine hydrochloride, benextramine, indoramine, and yohimbine; clonidine HCl and functionally similar agents such as guanabenz, guanfacine, lofexidine, and UK No. 14,304; labetalol and other combined alpha and beta blocking agents such as prizidolol and peroxidil.
    Type: Grant
    Filed: September 27, 1982
    Date of Patent: July 30, 1985
    Inventor: K. David G. Edwards
  • Preventing renal failure employing nicotinic acid
    Patent number: 4472410
    Abstract: A method and substances are featured for reducing the risk of incurring renal damage or failure. Substances useful in the treatment of hyperlipidemia and closely-related vascular conditions have been found to reduce or prevent renal failure. The substances most generally utilized are derivatives of phenoxyacetic acid. These substances are administered from 0.01 to 0.25% by weight of the dietary materials ingested by the host which is equivalent to 0.2 to 6.0 grams per day in man.
    Type: Grant
    Filed: December 4, 1980
    Date of Patent: September 18, 1984
    Inventor: K. David G. Edwards
  • Renoprotective treatments employing vasodilator compounds
    Patent number: 4361564
    Abstract: A treatment method and substances have been found to reduce the risk of incurring renal damage or failure. Vasodilators useful for the treatment of hypertension have been found to lower cholesterol levels and prevent renal failure or damage. These substances are administered alone or in combination with other substances useful in the treatment of hyperlipidemia such as phenoxyacetic acid derivatives.
    Type: Grant
    Filed: February 9, 1981
    Date of Patent: November 30, 1982
    Inventor: K. David G. Edwards
  • Preventing renal failure
    Patent number: 4250191
    Abstract: A method and substances are featured for reducing the risk of incurring renal damage or failure. Substances useful in the treatment of hyperlipidemia and closely-related vascular conditions have been found to reduce or prevent renal failure. The substances most generally utilized are derivatives of phenoxyacetic acid. These substances are administered from 0.01 to 0.25% by weight of the dietary materials ingested by the host which is equivalent to 0.2 to 6.0 grams per day in man.
    Type: Grant
    Filed: November 30, 1978
    Date of Patent: February 10, 1981
    Inventor: K. David G. Edwards